Depression development in patients with celiac disease
DOI:
https://doi.org/10.12775/JEHS.2023.13.02.002Keywords
celiac disease, depression, gluten-free dietAbstract
Due to the increasing number of patients suffering from celiac disease (CD) and difficulties in diagnosing, scientists raise awareness of different symptoms that patients might present. CD is an autoimmune, genetical disease of small intestine however, symptoms might be related to many different systems apart from gastrointestinal one, for instance nervous system.
A common and non-specific symptom of untreated CD might be depression. A gluten intake by patients with genetical predisposition results in antibodies production which can affect central nervous system causing depression. Moreover, we observe imbalance between amino acids and its metabolites, for example serotonin, which lead to mood disorder.
In those patients who suffer from drug-resistant depression, testing for CD should be done and if they are positive, the patient should immediately start a gluten-free diet. This action could reduce symptoms of depression.
The following article is a review of current knowledge related to correlation between CD and depression, its pathomechanism and gluten-free diet as a possible way of treatment. This article is based on available publications in Pubmed and Google Scholar databases.
References
Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018 Jan 6;391(10115):70-81.
Caio, G., Volta, U., Sapone, A. et al. Celiac disease: a comprehensive current review. BMC Med 17, 2019, 142
Downey L, Houten R, Murch S, et. al. for the Guideline Development Group. Recognition, assessment, and management of coeliac disease: summary of updated NICE guidance. BMJ 2015; 351: h4513.
https://celiakia.pl/celiakia/diagnoza/
Fernández Bañares F, Mariné M, Rosinach M, et. al. Type 1 Marsh Celiac Disease: Diagnosis and Response. In Rodrigo L and Peña AS, editors. Celiac Disease and Non-Celiac Gluten Sensitvity. Barcelona, Spain: OmniaScience; 2014. p. 289-302.
Casella G, Bordo BM, Schalling R, et. al.. Neurological disorders and celiac disease. Minerva Gastroenterol Dietol. 2016 Jun ;62(2):197-206.
Losurdo G, Principi M, Iannone A, et. al. Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm. World J Gastroenterol. 2018 Apr 14;24(14):1521-1530.
Troncone R, Ivarsson A, Szajewska H, et. al; Members of European Multistakeholder Platform on CD (CDEUSSA). Review article: future research on coeliac disease - a position report from the European multistakeholder platform on coeliac disease (CDEUSSA). Aliment Pharmacol Ther. 2008 Jun 1;27(11):1030-43.
Zingone F, Swift GL, Card TR, et. al. Psychological morbidity of celiac disease: A review of the literature. United European Gastroenterol J. 2015 Apr;3(2):136-45.
Smith, D. F., & Gerdes, L. U. (2011). Meta-analysis on anxiety and depression in adult celiac disease. Acta Psychiatrica Scandinavica, 125(3), 189–193.
Lindfors, K., Ciacci, C., Kurppa, K., et. al. (2019). Coeliac disease. Nature Reviews Disease Primers, 5(1).doi:10.1038/s41572-018-0054-z
Siddiqui K, Uqaili AA, Rafiq M, et. al. Human leukocyte antigen (HLA)-DQ2 and -DQ8 haplotypes in celiac, celiac with type 1 diabetic, and celiac suspected pediatric cases. Medicine (Baltimore). 2021 Mar 19;100(11):e24954.
Lundin KE, Wijmenga C. Coeliac disease and autoimmune disease-genetic overlap and screening. Nat Rev Gastroenterol Hepatol. 2015;12:507–15.
Dieli-Crimi R, Cénit MC, Núñez C. The genetics of celiac disease: a comprehensive review of clinical implications. J Autoimmun. 2015;64:26–41
Clemente MG, De Virgiliis S, Kang JS, et al. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut. 2003;52:218–23
Sander GR, Cummins AG, Henshall T, et. al. Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. FEBS Lett. 2005;579:4851–5.
Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797–801.
Molberg O, Mcadam SN, Körner R, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998; 4: 713–17.
Lundin KE, Scott H, Hansen T, et al. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993; 178: 187–96.
Bodd, M. et al. HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22. Mucosal Immunol. 3, 594–601 (2010).
Dunne MR, Byrne G, Chirdo FG and Feighery C (2020) Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder. Front. Immunol. 11:1374.
Hadjivassiliou M, Aeschlimann P, Strigun A, et. al. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol. 2008;64:332-
Zis P, Rao DG, Sarrigiannis PG, et. al.. Transglutaminase 6 antibodies in gluten neuropathy. Dig Liver Dis. 2017;49:1196-1200.
Markku Mäki, Pekka Collin, Coeliac disease, The Lancet, Volume 349, Issue 9067, 1997, Pages 1755-1759, ISSN 0140-6736
A. Hernanz, I. Polanco. Plasma precursor amino acids of central nervous system monoamines in children with coeliac disease. Gut, 32 (1991), pp. 1478-1481
Møller SE, Kirk L, Honore ́ P. Relationship between plasma ratio of tryptophan to competing amino acids and the response to L-tryptophan treatment in endogenously depressed patients. J Affect Disord 1980;2:47–59.
Fernstrom JD, Faller DV. Neutral amino acids in the brain: Changes in response to food ingestion. J Neurochem 1978;30: 1531– 8.
Corvaglia, L. (1999). Depression in adult untreated celiac subjects: diagnosis by the pediatrician. The American Journal of Gastroenterology, 94(3), 839–843.
Hallert C, Derefeldt T. Psychic disturbances in adult coeliac disease. I. Clinical observations. Scand J Gastroenterol. 1982 Jan;17(1):17-9.
HALLERT, C., SVENSSON, M., THOLSTRUP, J. and HULTBERG, B. (2009), Clinical trial: B vitamins improve health in patients with coeliac disease living on a gluten-free diet. Alimentary Pharmacology & Therapeutics, 29: 811-816.
Hadjivassiliou M, Gibson A, Davies-Jones GA, et. al. Does cryptic gluten sensitivity play a part in neurological illness? Lancet. 1996 Feb 10;347(8998):369-71
Dohan FC. Coeliac disease and schizophrenia. Lancet 1970; i:897– 8.
Päivi A. Pynnönen, Erkki T. Isometsä, Eeva et. al. Mental Disorders in Adolescents With Celiac Disease,
Psychosomatics, Volume 45, Issue 4, 2004, Pages 325-335, ISSN 0033-3182,
G. Ljungman, U. Myrdal. Compliance in teenagers with coeliac disease—a Swedish follow-up study. Acta Paediatr, 82 (1993), pp. 235-238
Corvaglia L, Catamo R, Pepe G, et. al. Depression in adult untreated celiac subjects: diagnosis by the pediatrician. Am J Gastroenterol. 1999 Mar;94(3):839-43.
Simsek S, Baysoy G, Gencoglan S, et. al. Effects of Gluten-Free Diet on Quality of Life and Depression in Children With Celiac Disease. J Pediatr Gastroenterol Nutr. 2015 Sep;61(3):303-6.
Barratt SM, Leeds JS, Sanders DS. Factors influencing the type, timing and severity of symptomatic responses to dietary gluten in patients with biopsy-proven Coeliac disease. J Gastrointestin Liver Dis 2013; 22
van Hees NJ, Van der Does W, Giltay EJ. Coeliac disease, diet adherence and depressive symptoms. J Psychosom Res. 2013 Feb;74(2):155-60.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Agata Pikulicka, Małgorzata Piekarska, Katarzyna Pacek, Radosław Kasperski, Klaudia Jedlina, Izabela Szulc, Weronika Swacha
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 762
Number of citations: 0